| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6137308 | Transactions of the Royal Society of Tropical Medicine and Hygiene | 2010 | 11 Pages |
Abstract
Evidence from the trials identified for this review draw a fairly clear conclusion about the relative efficacy and safety of CQ for treating uncomplicated P. vivax malaria infection. However, further research in this field with well powered, randomized, non-inferiority design, using the standardized protocol is needed.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Cho Naing, Kyan Aung, Daw-Khin Win, Mak Joon Wah,